Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 8/20 | 1.00 |
| ▸ | TSHR | P16473 | 2/20 | 0.73 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | THRB | P10828 | 1/20 | 0.53 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA9 | Q16790 | 1/20 | 0.44 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.43 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.43 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.43 |
| ▸ | GBA1 | P04062 | 1/20 | 0.41 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL108754 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL753044 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL109289 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL6104785 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL614393 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| Dymanthine SCHEMBL8744671 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL25269808 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL225887 | 1.00 | DNM1 (1.00) | DNM1TSHRALDH1A1THRBCA12 | |
| SCHEMBL8463347 | 1.00 | — | — | |
| SCHEMBL158743 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 421 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116376532-B | Carbon dioxide foam flooding channeling-preventing agent suitable for fractured ultralow permeability reservoir and application thereof | 西南石油大学 | 2024-06-07 | — | — | CN | claimed |
| CN-116285934-B | Gel channeling inhibitor suitable for expanding sweep volume of carbon dioxide flooding of ultralow permeability reservoir and application thereof | 西南石油大学 | 2024-05-28 | — | — | CN | claimed |
| CN-117899859-A | Preparation method of cyclohexene catalyst prepared by benzene selective hydrogenation | 湖北兴发化工集团股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-116410100-A | Polymerizable cationic surfactant, hydrophobically associating polyacrylamide and preparation method | 中国石油天然气股份有限公司 | 2023-07-11 | — | — | CN | claimed |
| CN-116376532-A | Carbon dioxide foam flooding channeling-preventing agent suitable for fractured ultralow permeability reservoir and application thereof | 西南石油大学 | 2023-07-04 | — | — | CN | claimed |
| CN-116285934-A | Gel channeling inhibitor suitable for expanding sweep volume of carbon dioxide flooding of ultralow permeability reservoir and application thereof | 西南石油大学 | 2023-06-23 | — | — | CN | claimed |
| EP-2566874-B1 | SOLVENT-FREE ORGANOSILANE QUATERNARY AMMONIUM COMPOSITIONS, METHOD OF MAKING AND USE | RESOURCE DEV LLC (US) | 2023-01-18 | — | — | EP | claimed |
| CN-114736142-A | Oil field sewage sterilization and degreasing agent, and synthetic method and application thereof | 山东科兴化工有限责任公司 | 2022-07-12 | — | — | CN | claimed |
| EP-3165561-B1 | RAPID CURING THIOL EPOXY RESIN WITH IMPROVED COMPRESSION STRENGTH PERFORMANCE | BOEING CO (US) | 2021-01-13 | — | — | EP | claimed |
| US-10113049-B2 | Thermoplastic resin composition | NIPPON NYUKAZAI CO., LTD. (JP) | 2018-10-30 | — | — | US | claimed |
| CN-104226188-B | A kind of quaternary cationics and preparation method thereof | QIQIHAR UNIV. (CN) | 2015-12-09 | — | — | CN | claimed |
| US-20150329698-A1 | THERMOPLASTIC RESIN COMPOSITION | NIPPON NYUKAZAI CO., LTD. (JP) | 2015-11-19 | — | — | US | claimed |
| CN-104226188-A | Quaternary ammonium salt cationic surface active agent and preparation method thereof | UNIV QIQIHAR | 2014-12-24 | — | — | CN | claimed |
| US-8735618-B2 | Solvent-free organosilane quaternary ammonium compositions, method of making and use | RESOURCE DEVELOPMENT L.L.C. (US) | 2014-05-27 | — | — | US | claimed |
| EP-2566874-A2 | SOLVENT-FREE ORGANOSILANE QUATERNARY AMMONIUM COMPOSITIONS, METHOD OF MAKING AND USE | Resource Development L.L.C. (US) | 2013-03-13 | — | — | EP | claimed |
| US-20120125226-A1 | Solvent-Free Organosilane Quaternary Ammonium Compositions, Method of Making and Use | RESOURCE DEVELOPMENT L.L.C. (US) | 2012-05-24 | — | — | US | claimed |
| US-20110271873-A1 | Solvent-Free Organosilane Quaternary Ammonium Compositions, Method of Making and Use | Resource Development, LLC (US) | 2011-11-10 | — | — | US | claimed |
| WO-2011140451-A2 | SOLVENT-FREE ORGANOSILANE QUATERNARY AMMONIUM COMPOSITIONS, METHOD OF MAKING AND USE | RESOURCE DEVELOPMENT L.L.C. (US) | 2011-11-10 | — | — | WO | claimed |
| US-5646241-A | ADHESIVES | QUANTUM MATERIALS, INC. (US) | 1997-07-08 | — | — | US | claimed |
| WO-1996035760-A1 | BLEED RESISTANT CYANATE ESTER-CONTAINING COMPOSITIONS | QUANTUM MATERIALS, INC. (US) | 1996-11-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120125226-A1 | Solvent-Free Organosilane Quaternary Ammonium Compositions, Method of Making and Use | VDAC1, CUTA, HVCN1 | DNM1 876/4885TSHR 4335/4885ALDH1A1 3306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.